T1	Pharmacological_substance 33 43	tacrolimus
N1000 	Reference T1 MeSH:D016559	tacrolimus
T2	Pharmacological_substance 48 60	lansoprazole
N1001 	Reference T2 MeSH:D064747	lansoprazole
T3	Pharmacological_substance 107 119	voriconazole
N1002 	Reference T3 MeSH:D065819	voriconazole
T8	Pharmacological_substance 209 219	tacrolimus
N1003 	Reference T8 MeSH:D016559	tacrolimus
T9	Pharmacological_substance 230 242	lansoprazole
N1004 	Reference T9 MeSH:D064747	lansoprazole
T10	Pharmacological_substance 244 247	LAN
N1005 	Reference T10 MeSH:D064747	LAN
T15	Pharmacological_substance 433 443	tacrolimus
N1006 	Reference T15 MeSH:D016559	tacrolimus
T16	Pharmacological_substance 449 461	lansoprazole
N1007 	Reference T16 MeSH:D064747	lansoprazole
T19	Pharmacological_substance 713 725	voriconazole
N1008 	Reference T19 MeSH:D065819	voriconazole
T20	Pharmacological_substance 727 730	VCZ
N1009 	Reference T20 MeSH:D065819	VCZ
T25	Disorder 840 870	anaplastic large cell lymphoma
N1 	Reference T25 UMLS:C0206180	anaplastic large cell lymphoma
T26	Disorder 960 985	graft-versus-host disease
N2 	Reference T26 UMLS:C0018133	graft-versus-host disease
T27	Disorder 987 991	GVHD
N3 	Reference T27 UMLS:C0018133	GVHD
T29	Pharmacological_substance 1086 1089	VCZ
N1010 	Reference T29 MeSH:D065819	VCZ
T34	Pharmacological_substance 1487 1490	VCZ
N1011 	Reference T34 MeSH:D065819	VCZ
T36	Pharmacological_substance 1577 1580	VCZ
N1012 	Reference T36 MeSH:D065819	VCZ
T37	Pharmacological_substance 1597 1621	liposomal amphotericin B
N1013 	Reference T37 MeSH:C068538	liposomal amphotericin B
T39	Disorder 1791 1799	lymphoma
N4 	Reference T39 UMLS:C0024299	lymphoma
T40	Pharmacological_substance 1824 1833	acyclovir
N1014 	Reference T40 MeSH:D000212	acyclovir
T41	Pharmacological_substance 1835 1855	ursodeoxycholic acid
N1015 	Reference T41 MeSH:D014580	ursodeoxycholic acid
T42	Pharmacological_substance 1857 1865	cefepime
N1016 	Reference T42 MeSH:C043266	cefepime
T43	Pharmacological_substance 1867 1876	meropenem
N1017 	Reference T43 MeSH:C059500	meropenem
T44	Pharmacological_substance 1878 1888	vancomycin
N1018 	Reference T44 MeSH:D014640	vancomycin
T45	Pharmacological_substance 1890 1901	lenograstim
N1019 	Reference T45 MeSH:C082437	lenograstim
T46	Pharmacological_substance 1907 1929	dopamine hydrochloride
N1020 	Reference T46 MeSH:D004298	dopamine hydrochloride
T53	Pharmacological_substance 2202 2205	VCZ
N1021 	Reference T53 MeSH:D065819	VCZ
T5	Pharmacological_substance 221 224	TAC
N1022 	Reference T5 MeSH:D016559	TAC
T6	Pharmacological_substance 562 565	TAC
N1023 	Reference T6 MeSH:D016559	TAC
T11	Pharmacological_substance 1655 1658	TAC
N1024 	Reference T11 MeSH:D016559	TAC
T13	Pharmacological_substance 1300 1303	LAN
N1025 	Reference T13 MeSH:D064747	LAN
T18	Pharmacological_substance 2140 2143	TAC
N1026 	Reference T18 MeSH:D016559	TAC
T21	Pharmacological_substance 2148 2151	LAN
N1027 	Reference T21 MeSH:D064747	LAN
T23	Pharmacological_substance 2583 2586	LAN
N1028 	Reference T23 MeSH:D064747	LAN
T28	Pharmacological_substance 2536 2539	TAC
N1029 	Reference T28 MeSH:D016559	TAC
T49	Subject 64 96	a bone marrow transplant patient
T61	Pharmacological_substance 669 672	TAC
N1030 	Reference T61 MeSH:D016559	TAC
T62	Pharmacological_substance 677 680	LAN
N1031 	Reference T62 MeSH:D064747	LAN
T64	Subject 789 816	An 18-year-old Japanese man
T65	Pharmacological_substance 912 915	TAC
N1032 	Reference T65 MeSH:D016559	TAC
T67	Pharmacological_substance 1070 1073	LAN
N1033 	Reference T67 MeSH:D064747	LAN
T68	Pharmacological_substance 1139 1142	TAC
N1034 	Reference T68 MeSH:D016559	TAC
T71	Pharmacological_substance 1360 1363	TAC
N1035 	Reference T71 MeSH:D016559	TAC
T74	Pharmacological_substance 1567 1570	LAN
N1036 	Reference T74 MeSH:D064747	LAN
T78	Pharmacological_substance 2194 2197	TAC
N1037 	Reference T78 MeSH:D016559	TAC
T79	Subject 2468 2481	a BMT patient
T81	Pharmacological_substance 2646 2649	VCZ
N1038 	Reference T81 MeSH:D065819	VCZ
T17	Subject 502 531	CYP3A5 extensive metabolizers
T83	Negation_cue 462 468	failed
T84	Combination 708 712	with
